1、 Jiechen Liu; Guangrui Liu; Chunlei Dai; Jun Wu; Qing Li ; Immune-Enhanced and Tumor-Targeted PDT Cascade Therapy for Oral Squamous Cell Carcinoma Utilizing a Carrier-Free BRD4 Inhibitor/PDT Agent Nanocomplex ; Chemical Engineering Journal , 2024 , 485(1)
2、 Wenbin Zhou; Yafei Gao; Xinyu Feng; Yanqing Zhang; Cong Yang; Lanxi He; Fenghe Zhang; Xiaoguang Li; Qing Li ; Biomimetic nanoplatform integrates FRET-enhanced photodynamic therapy and chemotherapy for cascaded revitalization of the tumor immune microenvironment in OSCC, Chinese Chemical Letters, 2025 , 36(1)
3、 Jiechen Liu; Xiaoguang Li; Ruiyang Xia; Yuqi Wang; Fenghe Zhang; Yongzhi Pang; Qing Li ; Efficient suppression of oral squamous cell carcinoma through spatial dimension conversion drug delivery systems-enabled immunomodulatory-photodynamic therapy, Chinese Chemical Letters, 2024 , 35(12)
4、 Wang, Miao; Zhao, Lu; Tong, Dongdong; Yane, Linrui; Zhu, Hongjie; Li,, Qing; Zhang, Fenghe ; BET bromodomain inhibitor JQ1 promotes immunogenic cell death in tongue squamous cell carcinoma, International Immunopharmacology, 2019, 76(6)
5、 Li Hongyu; Liu Yulin; Tan Wanye; Xiaoguang LI; Zhang Fenghe; Li Qing ; Structural and functional changes of nasal cavity and maxillary sinus in patients with skeletal class III malocclusion 1 year after bimaxillary surgery, Orthodontics & Craniofacial Research, 2022, 26(3)